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considered and kept in mind early and during the whole 
residency. This will not only be of value when applying for a 
job but will open a number of collaborations as well 
introducing the trainee in a virtuous circle which will 
tremendously facilitate future projects, recognition, 
satisfaction and professional pleasure.  
International exchanges and mobility are of utmost 
importance. From personal initiatives directly contacting a 
department head abroad via email or at a meeting to 
local/national or scientific societies programs there are many 
opportunities to gain such an enriching experience. ESTRO for 
instance supports short terms (few weeks) educational visits 
called mobility grants twice a year which allow for learning a 
specific technique in the context of a project propose by the 
candidate through a motivation letter which can be an 
excellent way to get some connections to look for longer 
term mobility. Entering a PhD program is another excellent 
opportunity to access the kind of international exchange and 
mobility that together with the scientific production and 
publication resulting from it will serve a career when looking 
for a position in a high level academic center. Indeed, having 
an international professional experience and a strong 
scientific background will be highly considered when applying 
for a job offer in a university hospital or a cancer center. 
This will even be almost mandatory when aiming at a 
research/teaching position. 
Mentorship can be very helpful throughout a career. 
Benefiting from privileged dialogue, support and guidance 
from a more experienced person in the field considered as a 
mentor can enhance the effectiveness of any talent, help 
avoiding painful mistakes and optimizing choices that will 
have a major career impact and sometimes even an impact 
on the balance between professional and personal life which 
is often a fragile point in a demanding profession. Many 
countries across Europe are lacking of mentorship programs 
but in many institutions even without a dedicated program 
various types of mentoring are in place. Most of more 
experienced people are happy to share their experience and 
give some advices so one should not hesitate to ask for this 
helpful interaction. With or without a mentor here are key 
questions that are essential to guide one’s choices:  
Who am I?  
Where do I want to go?  
What type of professional activity will I enjoy?  
Which life will make me happy?  
To conclude, the best advice would be to always wonder how 
to get the most out of one’s training period. In that aspect, 
ESTRO offers young professionals in the field of radiation 
oncology a wealth of opportunities from networking, grants, 
educational courses, fellowships, mentorships and workshops 
aiming at refining skills and gaining access to the latest 
developments in the field that will be of value finishing your 
residency not only with a job offer but with the job you 
want. 
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PhD training/residency is a long-term and enriching 
experience, it requires time and commitment for scientific 
achievement; in addition, the future of a young scientist 
needs to be planed ahead. Therefore, having a clear view of 
your carreer’s perspectives at least 18 months before your 
defense is the way to professional success. Early during your 
training discuss your career aspirations and important issues 
in your professional development with your mentor, he/she 
will be able to provide you with career information and 
guidance. But ultimately you will be the one to define if you 
are seeking for an academic career, job in the industry or 
other professional options. In any case your mentor will 
introduce you to colleagues, potential employers, and other 
professionals who might help to advance your career. You 
also need to be highly proactive and present your research 
and creative work as often as possible in multiple forums 
including your department/university but also at professional 
conferences/meeting. You will need to apply for fellowships, 
awards, teaching opportunities and service committees in the 
scientific community. The aim is to create a strong network 
that will serve as the base for your job research and will 
provide you with multiple opportunities.  
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Modern radiotherapy techniques focus on the precise 
irradiation of the target volume while minimizing the dose to 
adjacent normal tissues. Technical advances at all levels of 
the complex radiotherapy preparation and delivery process 
allowed reductions of safety margins and conformation of the 
high dose volume to the target volume. The introduction of 
these technical innovations has been supported by extended 
quality assurance procedures. A small part of the 
radiotherapy preparation process however has for a long time 
remained unaddressed: the quality of the target delineation 
is still a weak link in the radiotherapy chain.Accurate, 
unambiguous and precise target delineation is mandatory in 
high conformal radiotherapy, since the treatment plan and 
subsequently treatment delivery are based on the delineated 
target volumes. Errors in target delineation will on the one 
hand lead to systematic errors in treatment delivery and 
possibly to geographical misses in clinical practice. The 
projected outcome will be undermined both with respect to 
the chances of tumor control and the risks of side effects. On 
the other hand, inconsistencies in target volume contouring 
comprise the validity of the results of clinical trials.To 
improve the quality of the delineations, guidelines were 
made for nearly all tumor sites as well as for the normal 
tissues. Notwithstanding these published guidelines, 
important inter- and intra-observer variation in target 
delineation have been demonstrated. Several solutions have 
been proposed to improve the quality of target delineation: 
(1) for nearly all tumor sites delineation guidelines with 
complementary atlases have been published, (2) the 
registration of CT scans in treatment position with a 
combination of different imaging modalities has been tested 
and introduced, (3) automated and semi-automated 
delineation software has been developed, and (4) education 
through hands-on workshops at radiotherapy meetings and 
online tutoring sessions (e.g. FALCON) is available.Studies 
also show that peer review can improve delineation quality. 
The quality of target delineation was measured in Belgium 
through clinical audits for rectal and breast cancer patients. 
We have evaluated the role of a central review platform in 
improving uniformity of clinical target volume delineations 
within a national Belgian project. All 25 Belgian radiation 
oncology departments were invited to participate in this QA 
project. CTV delineation guidelines and atlases were 
discussed and distributed at a national meeting. After this 
education of the radiation oncologists, a review process was 
set up. Departments were asked to delineate the clinical 
target volumes and to upload it to a secured server. For 
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rectal cancer, the clinical target volume was delineated and 
for breast cancer, the regional nodal areas (internal 
mammary, level I to IV axillary and Rotter space) were 
contoured. A trained radiation technologist then reviewed all 
cases according to the guidelines and feedback was given 
within 24 hours. Twenty-four departments participated to the 
study and in total more than 2200 contours were reviewed: 
over 1200 rectal cancer patients and over 1000 breast cancer 
patients.Evaluation of the contours showed that 74 % of 
rectal cancer cases were modified. These high numbers 
indicate that the interpretation of guidelines is not always 
straightforward. More important however is the learning 
curve that was achieved. The rectal overlap and volumetric 
parameters significantly increased between the first ten 
patients per center and others. The study of the contouring 
of the locoregional nodal delineation in breast cancer is still 
ongoing and first results will be presented at presented at 
the ESTRO 35. For both breast and rectal cancer, some 
deficiencies in the description of the guidelines were 
demonstrated, making the interpretation ambiguous, and the 
guidelines will be adapted accordingly. Within a national QA 
project, we have shown that clinical audit of target 
delineation improves the quality of the contouring: the inter-
observer variability and the major deviations from the 
guidelines are substantially reduced. Variability in anatomical 
contouring contributes to uncertainty in treatment planning 
and compromises the quality of the treatment plan and 
delivered treatment. The standardization of tumor and target 
volume contouring is therefore highly desirable and can be 
positively influenced by consensus guidelines, education and 
clinical audits. 
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Current plan generation is an iterative trial-and-error 
procedure in which the planner tries to steer the treatment 
planning system (TPS) towards an acceptable plan by 
tweaking of parameters, such as beam angles, goal functions 
or weights. A plan is generally considered acceptable if it 
fulfills minimum requirements for tumour and OARs, while 
significant further improvement of the dose distribution is 
considered infeasible (within the allotted time). On top of 
the high workload, the current planning approach leads to 
suboptimal plan quality: the quality is strongly dependent on 
the skills and experience of the planner (operator 
dependence), plan quality is dependent on allotted time, and 
quality is dependent on subjective preferences and priorities 
of the planner and the treating physician. Can this variability 
be reduced? Can treatment planning be standardised? Can we 
guarantee that each patient will be treated with an 
individualised, clinically highly favourable (best) treatment 
plan when generated in an efficient manner? In this 
presentation, data will be provided demonstrating difficulties 
that clinicians encounter in evaluating treatment plans. 
Furthermore, the concept of automated treatment plan 
generation will be discussed as a procedure that may be used 
to standardise treatment planning. Examples of the positive 
impact on plan quality will be presented and consequences 
for involved personnel and plan quality assurance will be 
discussed.  
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Delineation of targets and normal tissues, typically 
performed on CT and/or MR images, is still one of the largest 
sources of variability in radiation therapy treatment plans. In 
fact, despite well-described guidelines for manual 
contouring, substantial intra and inter-observer variations 
exist. Moreover manual contouring is a time consuming 
process that, depending on the number and complexity of 
contours to be delineated, can hinder the implementation of 
adaptive radiotherapy approach. Current perspectives on 
contouring procedure suggest that an automated approach 
could reduce both the contouring time and inter-observer 
variations. Studies evaluating automated contouring in 
multiple disease sites have in fact demonstrated the 
potential to improve efficiency and variability associated 
with manual segmentation. In practice, automated contour 
are carried out using atlas-based, model-based or hybrid 
approaches. In atlas-based segmentation the CT scan of a 
new patient is segmented using segmented scans of one 
(single-patient) or more (multi-patient) previously treated 
patients, called atlases. Methods based on classical 
deformable models use local image features and 
automatically adapts the model shape to fit patient’s organ. 
Various implementations of these two principal methods are 
described in the literature and are available in commercial 
contouring software. Prior their clinical use automated 
contouring methods need an accurate validation. This is a 
challenging task as medical image segmentation lacks a 
known gold standard in its real world application. Phantoms 
as well as synthetic images provide an easily identifiable 
ground truth but are an unrealistic surrogate for patient 
imaging. Moreover, evaluation methods have also lacked 
consensus as to comparison metrics. A number of different 
methods have been utilized for comparing segmentation 
results. The common metrics used fall into one of two 
categories: volume based or distance based. Each of the 
comparison metrics has limitations and thus it is desirable to 
use multiple metrics where possible. This presentation will 
discuss the advantage in standardization deriving from the 
use of automatic contouring and the different approach 
followed in the implementation and validation of automated 
segmentation tools in different anatomical districts.  
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Standardisation of clinical practice is essential for the 
delivery of safe, accurate radiotherapy treatments. 
Implementation of new standards can be at both local and 
national levels and examples of these approaches, from an 
RTT perspective, will be discussed. New standards should be 
developed and implemented within a multi-professional team 
setting. Each profession has a role to play and bring different 
perspectives to the development and implementation 
process. 
Development of training and competency assessments for the 
use of new delivery techniques are an essential aspect of 
implementing any new standards. These assessments can be 
established locally using national guidelines. For example the 
UK National Radiotherapy Implementation Group IGRT 
recommendations1 which was written by a multi-profession 
team to assist centres in utilising IGRT equipment and details 
content for IGRT training and competency assessment 
programmes. This recommendation document has been 
instrumental in the UK with ensure appropriate utilisation of 
IGRT for each anatomical site and ensuring quality IGRT is 
delivered to patients. RTTs are also involved in the 
preparation of national SABR guidelines, as part of the UK 
SABR consortium, particularly focusing on the treatment 
delivery and IGRT sections. 
Clinical trials provide a controlled environment where new 
standards can be developed in a quality assured way. A UK 
prostate radiotherapy clinical trial utilised both IMRT and 
IGRT within the context of a study evaluating a number of 
fractionation schedules. This assisted the centres involved to 
develop IMRT and IGRT standards within their departments 
within a quality assured clinical trial. RTTs were able to use 
IGRT processes clearly defined within the protocol and the 
support of the QA team for the trial were available for advice 
